Shenglin Mei of Virginia Tech's Fralin Biomedical Research Institute was part of a multi-institutional team including researchers from Harvard Medical School, Massachusetts General Hospital, the ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

Thanks to cancer research, advances in treatment and imaging, the life expectancy is now much longer in comparison to decades ago, when men diagnosed with advanced stage 4 prostate cancer were ...

A new means of prostate cancer screening could emerge as an alternative for the PSA test, which has long been the first-line option. Researchers and doctors discuss the findings.

ZERO Prostate Cancer is alarmed by the President's Fiscal Year 2026 Budget, which proposes sweeping cuts that would jeopardize decades of progress in cancer research, prevention, and treatment.

The research — which was published in the journal Molecular Cancer — was based on studies on mice, as well as a retrospective study of 69 prostate cancer patients with Type 2 diabetes, all of ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for cross ...